Pharma-Bio Serv, Inc.
PBSV · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | 81,118.3% | -2.2% | 5.9% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 29.3% | 33.9% | 31.1% | 31.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16% | -4.1% | -3.7% | -6.6% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | $0 | $0 | -$0 |
| Tax Expense | -$0 | $0 | $0 | -$0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -0% | 3.9% | 0.3% | 0.7% |
| EPS | -0.009 | 0.004 | 0.37 | 0.035 |
| % Growth | -311.9% | -98.9% | 969.4% | – |
| EPS Diluted | -0.009 | 0.004 | 0.37 | 0.035 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0% | -1.6% | -1.7% | -4.6% |